Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease

被引：0
|
作者：
Kuhnowski F. [1 ]
Terriou L. [1 ]
Magro L. [1 ]
Jouet J.-P. [1 ]
Yakoub-Agha I. [1 ]
机构：
[1] Service des Maladies du Sang, UAM Allogreffes de CSH, CHRU, Lille
来源：
Drugs | 2006年 / 66卷 / Suppl 2期
关键词：
Imatinib; Tacrolimus; Chronic Myeloid Leukaemia; Mycophenolate Mofetil; Busulfan;
D O I：
10.2165/00003495-200666002-00009
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：29 / 31
页数：2
相关论文
共 50 条
  • [31] Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients
    Massari, P
    Duro-Garcia, V
    Girón, F
    Hernández, E
    Juárez, F
    Castro, C
    Toledo, M
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 916 - 919
  • [32] Enteric-coated mycophenolate sodium in addition to standard graft-versus-host disease prophylaxis in allogeneic stem cell transplantation
    Sayer, HG
    Mügge, LO
    Klink, A
    Scholl, S
    Schmidt, V
    Schilling, K
    Höffken, K
    BONE MARROW TRANSPLANTATION, 2006, 37 : S95 - S96
  • [33] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders
    Darji, P.
    Vijayaraghavan, R.
    Thiagarajan, C. M.
    Sharma, R. K.
    Subbarao, B.
    Pishardy, R.
    Dakshinamurthy, K. V.
    Vijaykumar, R.
    Abraham, G.
    Bhaskar, S.
    Agarwal, L.
    Shah, B.
    Abraham, A.
    John, M.
    Sampathkumar, K.
    Das, T.
    Umesh, L.
    Sundar, S.
    Ballal, H.
    Jasuja, S.
    Saxena, S.
    Saha, T. K.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) : 2262 - 2267
  • [34] Quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium
    Cofan, F.
    Rosich, E.
    Arias, M.
    Torregrosa, V.
    Oppenheimer, F.
    Campistol, J. M.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2179 - 2181
  • [35] Efficacy and safety of conversion of mycophenolate mofetil to enteric-coated mycophenolate sodium in Mexican renal transplant children
    Reyes, H.
    Hernandez, A. M.
    Valverde, S.
    Cataneo, A.
    Mendoza, A.
    Barrera, I.
    Ortiz, L.
    Garcia-Roca, P.
    Lopez-Martinez, B.
    Castaneda-Hernandez, G.
    Medeiros, M.
    PEDIATRIC TRANSPLANTATION, 2010, 14 (06) : 746 - 752
  • [36] Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium After Simultaneous Pancreas-Kidney Transplantation
    Rangel, E. B.
    Melaragno, C. S.
    Sa, J. R.
    Gonzalez, A. M.
    Linhares, M. M.
    Salzedas, A.
    Medina-Pestana, J. O.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4265 - 4269
  • [37] Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients
    Toledo, Alexander H.
    Hendrix, Laura
    Buchholz, Valorie
    Fisher, Erin
    Newton, Kimberly
    Smith, Courtney
    Gerber, David A.
    CLINICAL TRANSPLANTATION, 2012, 26 (01) : 156 - 163
  • [38] Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients
    Boehler, Torsten
    Canivet, Cindy
    Galvani, Sylvain
    Therville, Nicole
    Salvayre, Robert
    Negre-Salvayre, Anne
    Durand, Dominique
    Thomsen, Mogens
    Rostaing, Lionel
    Kamar, Nassim
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (05) : 769 - 773
  • [39] Enteric-coated mycophenolate sodium
    Gabardi, S
    Tran, JL
    Clarkson, MR
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1685 - 1693
  • [40] Enteric-coated mycophenolate sodium
    Budde, Klemens
    Duerr, Michael
    Liefeldt, Lutz
    Neumayer, Hans-Hellmut
    Glander, Petra
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (06) : 981 - 994
12345